These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35150072)

  • 1. Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months.
    Peled Y; Ram E; Mandelboim M; Lavee J; Sternik L; Segev A; Wieder-Finesod A; Halperin R; Indenbaum V; Levy I; Patel J; Raanani E; Lustig Y; Rahav G
    Am J Transplant; 2022 Jul; 22(7):1931-1932. PubMed ID: 35150072
    [No Abstract]   [Full Text] [Related]  

  • 2. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
    Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
    Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response to heterologous prime-booster vaccination in heart transplant recipients aged 18-70 years primed with a viral vector SARS-CoV-2 vaccine.
    Tanner R; Starr N; Perez-Garcia CN; Chan G; Dempsey E; Heffernan E; Lynch B; Hannan MM; Joyce E
    Transpl Infect Dis; 2022 Dec; 24(6):e13935. PubMed ID: 35980217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.
    Herrera S; Colmenero J; Pascal M; Escobedo M; Castel MA; Sole-González E; Palou E; Egri N; Ruiz P; Mosquera M; Moreno A; Juan M; Vilella A; Soriano A; Farrero M; Bodro M
    Am J Transplant; 2021 Dec; 21(12):3971-3979. PubMed ID: 34291552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - Implications for the omicron variant: Correspondence.
    Peled Y; Patel JK; Afek A; Mandelboim M
    J Heart Lung Transplant; 2022 Nov; 41(11):1649-1650. PubMed ID: 35961828
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
    Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
    Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.
    Marinaki S; Adamopoulos S; Degiannis D; Roussos S; Pavlopoulou ID; Hatzakis A; Boletis IN
    Am J Transplant; 2021 Aug; 21(8):2913-2915. PubMed ID: 33864722
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
    Stumpf J; Tonnus W; Paliege A; Rettig R; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Tonn T; Hugo C
    Transplantation; 2021 Nov; 105(11):e267-e269. PubMed ID: 34342963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
    Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.
    Chang A; Chiang TP; Kim JD; Mitchell J; Alejo JL; Jefferis AA; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Massie AB; Segev DL; Werbel WA
    Clin Transplant; 2022 Aug; 36(8):e14738. PubMed ID: 35670813
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.
    Sánchez-Zapardiel E; Alós M; Nozal P; González-Muñoz M; Frauca-Remacha E; Gavilán LB; Quiles MJ; Hierro L; López-Granados E
    Front Immunol; 2022; 13():1049188. PubMed ID: 36505469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to a third BNT162B2 COVID-19 vaccine after heart transplantation: Bridging the knowledge gap to end the pandemic for organ transplant recipients.
    Haidar G
    J Heart Lung Transplant; 2022 Oct; 41(10):1426-1428. PubMed ID: 35933295
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.
    Firket L; Descy J; Seidel L; Bonvoisin C; Bouquegneau A; Grosch S; Jouret F; Weekers L
    Am J Transplant; 2021 Nov; 21(11):3806-3807. PubMed ID: 34153162
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
    Nakazawa H; Sakai K; Sudo Y; Iwabuchi R; Sakai H; Nishina S; Kawakami T; Kawakami F; Matsuzawa S; Ito T; Kitahara M; Kamijo Y; Umemura T; Ushiki A; Kanai S; Tsuchiya H; Ishida F
    Transpl Immunol; 2022 Dec; 75():101713. PubMed ID: 36100196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
    Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
    Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
    Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
    Front Immunol; 2022; 13():832501. PubMed ID: 35281023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.
    Grupper A; Rabinowich L; Schwartz D; Schwartz IF; Ben-Yehoyada M; Shashar M; Katchman E; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Am J Transplant; 2021 Aug; 21(8):2719-2726. PubMed ID: 33866672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response.
    Masset C; Kerleau C; Garandeau C; Ville S; Cantarovich D; Hourmant M; Kervella D; Houzet A; Guillot-Gueguen C; Guihard I; Giral M; Dantal J; Blancho G
    Kidney Int; 2021 Nov; 100(5):1132-1135. PubMed ID: 34474075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.